NeoGenomics (NEO) COO nets shares after 17,562-unit RSU vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NeoGenomics Inc. President & Chief Operating Officer Warren Stone reported an equity compensation event on April 1, 2026. He exercised 17,562 restricted stock units into an equal number of shares of common stock at an exercise price of $0.00 per share.
Of these shares, 6,911 were disposed of through a tax-withholding transaction to satisfy tax obligations, a non-market event. Following these transactions, Stone directly holds 158,365 shares of NeoGenomics common stock, along with multiple outstanding stock option, restricted stock unit, and performance stock unit awards as listed in the filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
17,562 shares exercised/converted
Mixed
19 txns
Insider
Stone Warren
Role
Pres & Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 17,562 | $0.00 | -- |
| Exercise | Common Stock | 17,562 | $0.00 | -- |
| Tax Withholding | Common Stock | 6,911 | $0.00 | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 35,125 shares (Direct);
Common Stock — 165,276 shares (Direct);
Stock Option (Right to Buy) — 166,113 shares (Direct);
Performance Stock Unit — 21,204 shares (Direct)
Footnotes (1)
- On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. The restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. Once vested, the shares of common stock are not subject to expiration. On December 1, 2022, Mr. Stone was granted 166,113 stock options. The options vest ratably over the first four anniversary dates of the grant date. On May 11, 2023, Mr. Stone was granted 53,969 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. On February 23, 2024, Mr. Stone was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date. On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company. On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. On May 2, 2024, Mr. Stone was granted 29,976 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company. On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110% On February 21, 2025, Mr. Stone was granted 143,266 stock options. At the time of the grant, the options vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these options was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grantdate. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%. On April 1, 2025, Mr. Stone was granted 94,518 stock options. The options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 multiplied by 110%. On March 1, 2026, Mr. Stone was granted 253,378 stock options. The options vest ratably over the first three anniversary dates of the grant date. On March 1, 2026, Mr. Stone was granted 152,594 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Key Figures
RSUs exercised: 17,562 shares
Shares withheld for taxes: 6,911 shares
Direct common shares after transaction: 158,365 shares
+4 more
7 metrics
RSUs exercised
17,562 shares
Restricted Stock Units converted to common stock on April 1, 2026
Shares withheld for taxes
6,911 shares
Tax-withholding disposition related to RSU exercise
Direct common shares after transaction
158,365 shares
Total NeoGenomics common stock held directly by Warren Stone post-transaction
Stock options @ $11.21
166,113 underlying shares
Option grant expiring December 1, 2029 with $11.21 exercise price
Stock options @ $19.65
53,969 underlying shares
Option grant expiring May 11, 2030 with $19.65 exercise price
Premium-price options @ $10.81
253,378 underlying shares
Premium-price stock option grant expiring March 1, 2036 at $10.81
Outstanding RSUs from March 1, 2026 grant
152,594 units
Restricted stock units vesting over three years from February 21, 2025 grant date
Key Terms
Restricted Stock Unit, Performance Stock Unit, premium-price stock option, tax-withholding disposition, +1 more
5 terms
Restricted Stock Unit financial
"On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Performance Stock Unit financial
"Mr. Stone was granted 21,204 performance stock units representing the number of shares"
A performance stock unit is a type of reward companies give to employees, usually managers, that depends on how well the company performs over time. If the company hits specific goals, the employee earns shares of stock, like earning a prize for reaching certain levels in a game. It motivates employees to work hard because their rewards are tied to the company's success.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
weighted average price financial
"based on the weighted average price of the Company's common stock over the 20-day"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What insider transaction did NeoGenomics (NEO) COO Warren Stone report?
Warren Stone reported exercising 17,562 restricted stock units into NeoGenomics common stock. These units converted at an exercise price of $0.00 per share as part of his equity compensation, increasing his direct share ownership in the company.
What does the tax-withholding transaction mean in Warren Stone’s NeoGenomics Form 4?
The tax-withholding entry labeled with code F indicates 6,911 shares were surrendered to satisfy tax obligations from the RSU exercise. This is a standard, non-market mechanism and does not represent a discretionary sale of shares into the market.
What derivative awards does Warren Stone still hold in NeoGenomics (NEO)?
The filing lists several remaining derivative awards, including stock options and performance stock units. Examples are options over 166,113 shares at an $11.21 exercise price and 253,378 shares at a $10.81 exercise price, plus multiple restricted and performance stock unit grants.
Is Warren Stone’s NeoGenomics (NEO) Form 4 transaction mainly a buy or sell signal?
The Form 4 primarily reflects an acquisition of shares through RSU exercise, not an open-market trade. The only disposition is tax withholding, a routine step to cover taxes on vested equity rather than a voluntary sale decision.